Highlights of the San Antonio Breast Cancer Symposium 2022 - report from SABCS2022

from Medical Digest & Congress Report · host Medical Congress News

Professor Virginia Kaklamani speak about the novelties and state of the art treatment presented at SABCS 2022. (DESTINY-Breast02 trial Trastuzumab Deruxtecan,  CDK4/6i elacestrant, EMERALD trial, AKT inhibitor capivasertib,POSITIVE trial) Video: https://medicaldigest.org/scientific-contents/interview:highlights-san-antonio-breast-cancer-symposium-2022

Episode metadata supplied by the publisher feed · Published Dec 15, 2022

Embed this episode

Attribution link and audio player

Ready to play

Highlights of the San Antonio Breast Cancer Symposium 2022 - report from SABCS2022

0:00 4:57

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 4 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on December 15, 2022.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!